ScholarIQanswers from OpenAlex

Blocking podoplanin inhibits platelet activation and decreases cancer-associated venous thrombosis

PaperCitations, authors & open-access status

Blocking podoplanin inhibits platelet activation and decreases cancer-associated venous thrombosis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Blocking podoplanin inhibits platelet activation and decreases cancer-associated venous thrombosis have?

ScholarIQcitation count

Blocking podoplanin inhibits platelet activation and decreases cancer-associated venous thrombosis has 41 citations in the OpenAlex counts ScholarIQ stores.

When was Blocking podoplanin inhibits platelet activation and decreases cancer-associated venous thrombosis published?

ScholarIQyear

Blocking podoplanin inhibits platelet activation and decreases cancer-associated venous thrombosis has 2021 year in the ScholarIQ index.

What is the open-access status of Blocking podoplanin inhibits platelet activation and decreases cancer-associated venous thrombosis?

ScholarIQoa status

Blocking podoplanin inhibits platelet activation and decreases cancer-associated venous thrombosis has closed oa status in the ScholarIQ index.

What is the DOI of Blocking podoplanin inhibits platelet activation and decreases cancer-associated venous thrombosis?

ScholarIQdoi

The DOI for Blocking podoplanin inhibits platelet activation and decreases cancer-associated venous thrombosis is on the source record.

What is the PMID of Blocking podoplanin inhibits platelet activation and decreases cancer-associated venous thrombosis?

ScholarIQpmid

The PMID for Blocking podoplanin inhibits platelet activation and decreases cancer-associated venous thrombosis is on the source record.

What is the OpenAlex record for Blocking podoplanin inhibits platelet activation and decreases cancer-associated venous thrombosis?

ScholarIQopenalex

The OpenAlex for Blocking podoplanin inhibits platelet activation and decreases cancer-associated venous thrombosis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial